EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The incidence of serious complications after selective laser trabeculoplasty

Eeva S Ojanen iD, Joni A Turunen iD, Mika Harju iD

Acta Ophthalmologica · 2026

DOI: 10.1111/aos.17536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Eeva S Ojanen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Trabeculectomy, Postoperative Complications, Visual Acuity, Laser Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Silmä- ja kudospankkisäätiö, Glaukooma Tukisäätiö Lux, Silmäsäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT).

Methods

All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018. Data regarding patients' demographics, procedure details, complications, predisposing factors and clinical outcomes were extracted retrospectively from electronic medical records. The primary outcome measures were serious complications, including corneal oedema, corneal scarring, hyperopic shift, synechia, anterior chamber bleeding and hyphema.

Results

A total of 6081 SLTs (4601 eyes) of 2812 patients were analysed. Twelve patients had bleeding in the anterior chamber angle (incidence 2/1000 SLT laser treatments), and four of them developed hyphema (incidence 0.7/1000 SLT laser treatments). Corneal oedema or Descemet's membrane folds were reported in six treated eyes, resulting in an incidence of 1/1000. One myopic eye had a permanent corneal scarring, thinning and irregular astigmatism with a hyperopic shift (5.3 D with recovery to 1.25 D in three years), resulting in poor visual acuity (from preoperative 0.9 to 0.4 at the last control). The incidence was less than 0.2/1000 for all SLT treatments (95% CI ≤0.1 to 1.0) and 1/648 for SLT laser treatments in high myopia (spherical equivalent ≤−5.00 D).

Conclusions

After SLT, the number of complications was low, with only one permanent vision deterioration after 6081 treatments. These findings may help clinicians reassure patients about SLT safety when offering SLT as a first‐line treatment for ocular hypertension or open‐angle glaucoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrabeculectomyPostoperative ComplicationsVisual AcuityLaser TherapyIntraocular PressureGlaucoma, Open-AngleGlaucomaHumansIncidenceFemaleRetrospective StudiesMaleAgedMiddle AgedFollow-Up StudiesAged, 80 and overAdultFinland

Stichwörter der Autor:innen

complicationglaucomahyperopic shifthyphemaselective laser trabeculoplasty

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Eye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.

ORCID-Profile: Eeva S Ojanen, Joni A Turunen, Mika Harju

Förderung

  • Silmä- ja kudospankkisäätiö
  • Glaukooma Tukisäätiö Lux
  • Silmäsäätiö
  • Hospital District of Helsinki and Uusimaa (HUS)
  • Helsingin ja Uudenmaan Sairaanhoitopiiri

Zitieren

APA

Ojanen, E. S., Turunen, J. A., & Harju, M. (2026). The incidence of serious complications after selective laser trabeculoplasty. Acta Ophthalmologica. https://doi.org/10.1111/aos.17536

Vancouver

Ojanen ES, Turunen JA, Harju M. The incidence of serious complications after selective laser trabeculoplasty. Acta Ophthalmologica. 2026. doi:10.1111/aos.17536

BibTeX
@article{Ojanen2026,
  author = {Ojanen, Eeva S and Turunen, Joni A and Harju, Mika},
  title = {The incidence of serious complications after selective laser trabeculoplasty},
  journal = {Acta Ophthalmologica},
  year = {2026},
  doi = {10.1111/aos.17536}
}
Kostenlos starten →